Key facts
- It has raised $13.8M; the latest was Later Stage VC ($13.8M) in Mar 2025.
- Notable investors include Huagai Capital, Tenyall Investment.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Shanghai BioScience
- ·The full record, as it builds
Funding rounds
No funding rounds for Shanghai BioScience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shanghai BioScience
Provider of platform service focusing on life science services. The company's solution is multi-dimensional product matrix, supporting clients to meet the needs of different scientific research and production scenarios.
- Sector
- Business Products and Services (B2B)
- HQ
- Shanghai, China
- Founded
- 2005
- Employees
- 600
- Website
- bioscience.com.cn/
- Ownership
- Privately Held (backing)
Shanghai BioScience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shanghai BioScience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shanghai BioScience in its N-PORT filings yet. We sweep new filings monthly.